Publications & Reports
Find Publications by Keyword, Topic, or Author
Search all publications by keyword
Browse by Topic:
American Indians / Alaska Natives
Cannabis
Harm reduction
HIV/AIDS/Sexual Risk Behavior
Gender/LGBTQ+
Stimulants (methamphetamine, cocaine)
Opioids/Overdose Prevention
Pregnant & Parenting Women/FASD
Treatment
State & County Drug Trends
Youth/Young Adults/College
Search by ADAI Author
Recent Publications & Presentations
Need help getting a copy of an ADAI publication? Email ADAI’s Director of Information Services Meg Brunner, MLIS: meganw@uw.edu.

Adolescent and young adult access to opioid use disorder care.
Ball A, Winstead T, Singh S, Floyd A, Banta-Green C.
Pediatrics 2025;156(1):e2024070224

Conducting an implementation intervention study with American Indian and Alaska native communities: Methodological considerations.
Paschen-Wolff MM, Campbell ANC . . . Radin S, et al.
Contemporary Clinical Trials 2025: 107992.

Using structural equation modeling to examine barriers and facilitators of HIV pre-exposure prophylaxis willingness and length of use in men who have sex with men who use substances in eight Southern US cities.
Ertl M, Woodhouse C, Meche D, Forrest DW, Fegley JP, Paschen-Wolff M, Laschober TC, Hatch MA, Nelson CM, Wright L, Tross S. AIDS Patient Care and STDs 2025;39(6):245-256.

Cannabis consumer patterns, adverse events, and cannabis risk beliefs: A latent profile analysis in WA State.
Garrett SB, Williams J, Carlini BH, Hammond D.
Drug and Alcohol Dependence 2025 (in press).

Assessing Engagement in Cannabis Policy: A Survey of Washington State Elected Officials.
Kellum LB, Carlini BH, Garrett S.
Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, May 2025.

Centering peers in design and training for a peer-delivered contingency management program for self-identified harm reduction and treatment goals.
Peng L, Stack E, Cooke A, Hartzler B, et al.
Harm Reduction Journal 2025;22(suppl 1):72.

Attitudes toward and experience with naloxone among people who use drugs in the Southeastern United States.
Le MH, Laschober TC, Tross S, Paschen-Wolff M, Ertl MM, Wright L, Hatch MA.
International Journal of Drug Policy 2025; 139:10479.

Substance use and mental health symptoms in adults with prenatal alcohol exposure.
Hunnicut-Ferguson K, Stoner SA, Kable JA, Grant TM, Coles CD.
Neurotoxicology and Teratology 2025; 109:107436.

Criminal justice staff’s professional quality of life and interactions with justice-involved individuals: The moderating role of stigma.
Siebert SL, Owens MD, Folk JB, Moore KE. Deviant Behavior 2025;46(6):803-819.

The peers expanding engagement in stimulant harm reduction with contingency management study: A protocol paper.
Cooke A, Stack E, Peng L, Cook R, Hartzler B, et al.
Addiction Science & Clinical Practice 2025;20:48.

“I think one enhances the other”: Use of harm reduction and drug treatment among participants of syringe services programs.
Newman A, Winstead T, Layman L.
Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, June 2025.

Harm reduction without supportive policing: Experiences of drug users in Nepal.
Jha C, Donovan DM.
Journal of Social, Behavioral & Health Sciences 2025;19:1-17.

Healing of the Canoe: Preliminary suicide prevention outcomes among participating and non-participating youth.
Perkins T, Lee B, Mackin J, Donovan D, et al.
Prevention Science 2025 (in press).

Perceptions of Substance Use in Permanent Supportive Housing: Results from the 2024 State PerCH Staff Survey.
Petersky S, Banta-Green CJ.
Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, March 2025.

Adapting to the fentanyl epidemic: Rapid qualitative observations and derived clinical and research implications from the Emergency Department Longitudinal Integrated Care (ED-LINC) randomized clinical trial.
Lovett K, Zatzick D, … Banta-Green CJ, Whiteside LK.
Psychiatry 2025 (in press).

Factors associated with PrEP awareness and use among men who have sex with men who use drugs in the Southern United States.
Paschen-Wolff MM, Tross S, Nelson CM, Hatch MA, Meche D, Ertl MM, Wright L, Laschober TC.
AIDS Care 2024 (in press).

Willingness to Use Oral and Long-Acting Injectable PrEP in Substance-Using Men Who Have Sex with Men (SU-MSM) in High HIV Incidence Southern U.S. Cities: A NIDA Clinical Trials Network Study.
Tross S, Laschober TC, Paschen-Wolff M, Ertl M, Nelson CM, Wright L, Lancaster C, Feaster DJ, Monger M, Toal P, Fegley JP, Meche D, Hankey C, Woodhouse C, Spector A, Dresser L, Moran L, Jelstrom E, Haynes LF, Shoptaw S, Hatch MA.
AIDS & Behavior 2025;29(4):1192-1204.